The allosteric control of aspartate transcarbamoylase (ATCase, EC 2.1.3.2) of Escherichia coli involves feedback inhibition by both CTP and UTP rather than just CTP alone. It has been known that CTP functions as a heterotropic inhibitor of catalysis; however, the inhibition by CTP alone is incomplete (50-70% at various aspartate concentrations) and there is only a partial occupancy of the allosteric binding sites by CTP at saturating concentrations. The logic of these allosteric characteristics can now be understood in that UTP is a synergistic inhibitor of ATCase in the presence of CTP even though UTP has no independent effect at pH 7.0. When saturating concentrations of CTP are present, the concentration of substrate required for half-maximal activity (So.s) of the native holoenzyme for aspartate increases from 5 to 11 mM. When CTP and UTP are both present, the aspartate requirement increases further (S0.5 = 17 mM). At aspartate concentrations <5 mM, the heterotropic inhibition of ATCase is 90-95% in the presence of both pyrimidine nucleotides. UTP does enhance the binding of CTP to the holoenzyme but the number of tight binding sites does not change (n = 3). Biol. 196, have described a structural asymmetry across the molecular two-fold axis that is consistent with these CTP/UTP interactions. The synergistic inhibition of ATCase by both CTP and UTP provides a satisfying logic for ensuring a balance of endogenous pyrimidine nucleotide pools.
native holoenzyme for aspartate increases from 5 to 11 mM. When CTP and UTP are both present, the aspartate requirement increases further (S0.5 = 17 mM). At aspartate concentrations <5 mM, the heterotropic inhibition of ATCase is 90-95% in the presence of both pyrimidine nucleotides. UTP does enhance the binding of CTP to the holoenzyme but the number of tight binding sites does not change (n = The aspartate transcarbamoylase (ATCase, EC 2.1.3.2) of Escherichia coli provides a classic example of an enzyme subject to allosteric control by the end product of its biosynthetic pathway (1, 2) . The holoenzyme of ATCase is composed of two separable catalytic trimers (c3) and three regulatory dimers (r2) that interact through a variety of specific protein-protein interfaces (3, 4) . These interactions provide for specific conformational transitions (4-7) of the holoenzyme, 2(c3):3(r2), which result in changes in the catalytic rates and ligand affinities (8) (9) (10) . Upon binding of substrates and/or substrate analogues the enzyme appears to make a concerted transition from an inactive "T conformation" (condensed form of the enzyme) to an expanded, more active "R conformation" (5-7). CTP affects catalysis by increasing the concentration of aspartate required to produce maximal activity. In contrast, ATP decreases the substrate requirement without altering the Vmax of the enzyme (1, 2) . Both nucleotide effectors have been shown to competitively bind at the same allosteric sites even though they induce different heterotropic effects on catalysis (11) (12) (13) (14) . Other pyrimidine nucleotides, specifically UTP and TTP, do not have any effect. GTP does promote a significant inhibitory effect under some conditions (25-30%) but less than that of CTP (50-70%). 8-Bromoguanosine 5'-triphosphate, as well as gadolinium complexes of ATP, CTP, and GTP, binds to the regulatory subunits, whereas UTP does not appear to bind to the native enzyme (11) (12) (13) . These allosteric controls have been promoted for their inherent logic in balancing endogenous purine and pyrimidine nucleotide pools; however, there has always been a quantitative paradox relative to the incomplete inhibition by CTP (10, 14, 15) . In addition, it appears that there is discrete heterogeneity in CTP binding as half of the allosteric sites are capable of providing for high-affinity binding of CTP whereas three additional, lowaffinity sites have been identified in some studies (16) (17) (18) (19) .
A potential structural basis for this "half-site reactivity" has been provided by recent studies of Lipscomb and coworkers (20) in which a molecular asymmetry has been observed across the "two-fold axis of symmetry" of the CTP-liganded enzyme. In the presence of saturating concentrations of CTP, one of the allosteric sites of each dimer is fully occupied, whereas the second has an occupancy factor of <0.4. This asymmetry is translated into differences in the positioning of Arg-54 in the active sites and changes in the interface of the regulatory and catalytic subunits. Thus when the three CTP-binding sites on one side of the two-fold axis of symmetry are filled, the catalytic sites in that half assume a different conformation than the catalytic sites in the other half of the holoenzyme. Similarly, the partially filled allosteric binding sites on the opposing half of the enzyme adopt a different conformation than the completely filled CTPbinding sites. Even though both opposing sets of active sites and allosteric sites experience structural changes relative to the unliganded holoenzyme, the nature of those rearrangements is not identical. These differences appear to be divided between the opposing catalytic subunits of the oligomer such that the sites in each subunit are similar to one another but distinct from those in the other subunit. In the same manner, the allosteric sites in one half of the enzyme are occupied by CTP, whereas those in the other half are only partially occupied yet different from those observed in the unliganled enzyme.
The observations presented in these studies identify a role for UTP in completing the allosteric inhibition of ATCase by pyrimidine nucleotides and permit the development of a more complete model for metabolic regulation of pyrimidine biosynthesis. pPBhlO5 by transferring the Pst I-Sal I fragment into pUC8; ref. 21 ) and expressed in E. coli EK1104 (22) . To obtain homogeneous holoenzyme preparations it was necessary to utilize the heat step (720C) and a single pI precipitation (pH 5.9) of the purification procedures described by Gerhart and Holoubek (23) . The architectural purity of the enzyme was verified by nondenaturing activity gel analysis and/or chromatography on DEAE-Sephadex (24) . Enzymatic activity was determined as described (25, 26) in the presence of saturating carbamoyl phosphate (4.8 mM) and varying concentrations of aspartate depending upon the experimental purpose. The assays were all performed at pH 7.0, 280C with nucleotide effector concentrations varying from 0 to 12 mM.
MATERIALS AND METHODS
Equilibrium Dialysis. The equilibrium binding of nucleotide triphosphates was determined according to the general procedures of Tauc et al. (15) as modified to match the assay conditions used to analyze the synergism of CTP and UTP utilized in these studies (25) . Nucleotide concentrations were adjusted from 1 to 500 1LM, and the specific radioactivities of the 3H-labeled NTPs (ICN-Biochemicals) were adjusted to obtain -1000 cpm per 1l. The linearity of the equilibrium binding was evaluated over concentrations of ATCase from 0.03 to 30.0 mg/ml, and 3.0 mg/ml (10 1LM) was utilized for studies with [14CJCTP binding and 30 mg/ml was used for UTP binding studies. Equilibrium was ensured by evaluation after 36 and 72 hr at 40C. The purities of the radioactively labeled nucleotides were determined by HPLC analysis as described (27) .
EXPERIMENTAL RESULTS
Relative Activities for Combinations of Nucleotide Effectors. Table 1 summarizes the relative activities for various purine and pyrimidine nucleotide effectors independently and in combination. Saturating concentrations for each nucleotide (2 mM) were used throughout the studies and nucleotide effects were determined at the concentration of substrate required for half-maximal activity (So.5) of the unliganded enzyme (5 mM aspartate) and one-half that value (2.5 mM aspartate). In each study, the effect of the nucleotides was amplified at the lower substrate concentration. When saturating concentrations of nucleotides were mixed, as previously reported (27) , CTP reversed the activation by ATP. Other nucleotides had very little effect on the ATP-induced activation of ATCase; neither UTP nor GTP counteracted the ATP effect but actually promoted slight increases in activity.
The most interesting effects were observed from the combination of CTP and UTP, which resulted in a 90-95% inhibition of ATCase at both aspartate concentrations. This cooperative effect of CTP and UTP was maintained in the presence of either ATP or GTP. It should be noted that CTP was capable ofmaintaining inhibition in the presence ofeither purine nucleotide alone. When all four nucleotides were present simultaneously, slight inhibition (10-40%) was observed. These results were most important because they revealed a synergism between CTP and UTP in which UTP could contribute to the allosteric inhibition of ATCase even though it had no independent effect. In the presence of ATP, GTP contributed to the activation of the enzyme, in spite of its independent inhibitory effect, and provided a synergistic companion for ATP to compete with CTP and CTP/UTP combinations. Synergistic Inhibition of CTP and UTP. To evaluate whether the effect of combinations of CTP and UTP was a nucleotide-specific synergism or a concentration-dependent phenomenon, various overlapping effector response curves were analyzed. The results presented in Fig. 1 demonstrate that the UTP/CTP synergism was dependent upon both CTP and UTP and could not be mimicked by high concentrations of either nucleotide alone. Individual nucleotides demonstrated first-order saturation kinetics relative to their allosteric effects. When the CTP concentration was maintained at 2 mM and increasing concentrations of UTP were added, catalytic activity was reduced to 5-10% ofthe control values. Thus, it is clear that combinations of both CTP and UTP were required to effect maximal inhibition of the native ATCase from E. coli at pH 7.0. This effect is not as pronounced at pH 8.3 when UTP does have some independent inhibitory effect (-15-20%) (data not shown).
Saturation Kinetics of Nucleotide Effectors. Fig. 2 demonstrates that ATP appears to have a lower apparent binding affinity than CTP based on kinetic saturation responses, whereas UTP had no inhibitory effect at concentrations up to 12 mM. The half-saturating concentration for ATP activation was 0.8 mM, whereas CTP-induced inhibition required levels that were decreased by a factor of -5 (0.15 mM). This weaker binding of ATP has been described by others (19, 20) and would explain the dominance of CTP inhibition over ATP activation. The nature of this competitive advantage for CTP can be described in a slightly different manner by evaluating competitive saturation curves (data not shown). In these studies, increasing concentrations of either CTP or ATP were used to counteract saturating (2 mM) concentrations of the other allosteric effector. The concentrations of nucleotide required to overcome the effect of its antagonistic nucleotide (to adjust the relative activity of the reaction to that of the unaffected enzyme) were 0.8 mM CTP and =3.6 mM ATP. These results are consistent with the competition of ATP and CTP for the same binding sites with higher CTP-binding affinities.
Synergistic Interaction of CTP and UTP in Effecting Ailosteric Inhibition. Saturation studies with combinations of CTP and UTP were performed to evaluate the nature of the synergistic interaction between the two nucleotides (Fig. 3) . In the presence of saturating concentrations of either CTP or UTP (2 mM), the kinetic development of synergistic inhibition was more rapid than the partial inhibition induced by CTP alone. The requirement for maximal CTP inhibition was lower by a factor of -10 in the presence of UTP. Although the concentration ofCTP required for half-maximal inhibition was w0. 15 studies with UTP demonstrated that 4-12% of the total label was associated with protein dependent on the concentration of UTP, but it was not possible to complete a saturation study due to the insensitivity of the binding at higher concentrations. In this sense, UTP demonstrated the weak binding characteristic ofATP association rather than the tight binding of CTP. The presence of 2 mM CTP did not detectably enhance the binding of UTP to the ATCase holoenzyme (data not shown).
DISCUSSION
The ATCase of E. coli provides one of the classic models for allosteric regulation of catalytic activity in which the end product of a biosynthetic pathway controls the first unique enzyme of the pathway. Several detailed reviews have been published in recent years and describe an elegant enzyme subject to homotropic and heterotropic ligand responses (8) (9) (10) . As the endogenous CTP pools increase, the heterotropic inhibition of ATCase would directly modulate the de novo synthesis of pyrimidine nucleotides. Furthermore, pyrimidine nucleotide pools could be coordinated with purine nucleotide pools through the competition ofATP and CTP for the regulatory control of ATCase (11, 12, 14, 27) , resulting in an activation or inhibition of de novo pyrimidine biosynthesis. From a metabolic perspective, it would seem that the intracellular chemistry of the bacterial cell is poised to maximize these allosteric interactions since the endogenous metabolic pool for aspartate approximates the S0.5 ofATCase (5 mM) and the nucleotide pools are =0.5-1.0 mM for CTP and -2-3 mM for ATP (27) under conditions of steady-state growth in E. coli. These physiological conditions would provide the most sensitive responses for the allosterically regulated enzyme since endogenous ligand concentrations approximate the half-saturating values required for inducing homotropic and heterotropic effects in vitro.
Despite this textbook characterization of ATCase, there are a series of subtle incongruities that have been reported relative to the enzyme from E. coli:
(i) CTP only inhibits the enzyme 50-70o under various physical conditions, such as altered pH, substrate concentrations, or effector concentrations (1, 2, 10, 14, 27) .
(ii) CTP appears to have only three tight binding sites although it could be expected that there should be one equivalent binding site for each of the six regulatory polypeptides. This half-site reactivity has been described by several authors (16) (17) (18) (19) (Fig. 6 ). Elevated levels of intracellular pools of CTP alone would exert two simultaneous regulatory functions, as a partial inhibitor for the entire de novo pathway through ATCase (1, 2) and for direct control over its own synthesis through competitive inhibition of CTP synthetase (28) . Since CTP alone only partially inhibits ATCase, significant pyrimidine synthesis would continue; however, this would primarily serve to increase the UTP pool since the conversion of UTP to CTP would be restricted at CTP synthetase. Ultimately, CTP and UTP pools would be elevated, thus permitting the thorough inhibition of ATCase. Concomitant with the increasing triphosphate pools, an expanding UMP pool would provide for the inhibition of CPSase and reduce the production of carbamoylphosphate for pyrimidine and arginine biosyntheses (29, 30) . To ensure that elevated pyrimidine nucleotide pools do not result in the depletion of carbamoyl phosphate for arginine biosynthesis, ornithine specifically antagonizes the UMP inhibition of CPSase and is capable of independent activation (30) . When adequate levels of arginine are available, the ornithine pool decreases as the result of feedback of the first enzyme of the de novo pathway, N-acetylglutamate synthase (31) . In addition to the heterotropic controls emanating from the de novo pathways, various purine nucleotides (particularly, IMP and ATP) provide for the allosteric activation of CPSase and ATCase (1, 2, 29, 30 ). Thus elevated purine nucleotide pools would stimulate the de novo synthesis of pyrimidine nucleotides. The combination of CTP and UTP provides a synergistic control that effects the inhibition of ATCase in the presence of purine nucleotides, and IMP is capable of competitive activation of CPSase relative to UMP. In this manner, CPSase and ATCase are able to preside over the balancing of pyrimidine nucleotide pools with their purine counterparts in E. coli.
